Warm greetings. It’s my privilege to state that RIPER achieved a substantial milestone in planning and execution of societal befit oriented pharmaceutical research. To date, we have been granted about 2.3 crores by various central funding agencies including AICTE, UGC, DST, SERB, DBT, PCI and BIRAC. I am grateful to the principal administration, management members, honourable advisory board members and research staffs and scholars for their magnificent and sustainable contributions to the Research Division, for the continuous improvement of research facilities and collaborations to achieve RIPER RESEARCH VISION 2025. The remarkable facilities developed in recent years are Animal house with Zebrafish facility, CDSCO approved drug testing analytical facility, Molecular modelling & ADMET facility, DST-FIST funded research facilities, Cell culture and molecular biology unit, Nano-formulation unit and QbD tool support, Phytochemical isolation unit, Quality Control and Quality Assurance Unit. I relish the amount of encouragement rendered by all the external collaborators to the existing reputation of RIPER.

I appreciate the entire research team and our all external advisory members and welcome their support in future endeavours.